• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌的预后分类系统比较。

A comparison of prognostic classification systems for differentiated thyroid carcinoma.

机构信息

University of Würzburg, Department of Nuclear Medicine, Würzburg, Germany.

出版信息

Clin Endocrinol (Oxf). 2010 Jun;72(6):830-8. doi: 10.1111/j.1365-2265.2009.03734.x. Epub 2009 Oct 31.

DOI:10.1111/j.1365-2265.2009.03734.x
PMID:19863574
Abstract

OBJECTIVE

To identify and compare prognostic classification systems based on basic tumour characteristics that were developed and/or validated for differentiated thyroid carcinoma (DTC).

DESIGN

Retrospective chart study.

METHODS

Literature was studied using PubMed. Fifteen different prognostic classification systems were identified, of which seven were developed or validated for DTC patients and were based on basic tumour characteristics. These systems were applied to 1225 DTC patients who were treated in our hospital between 1978 and 2002.

RESULTS

Log-rank analysis of Kaplan-Meier cancer-specific survival curves showed that the curve of the Tumor, Lymph-Node, Metastasis (TNM) system had the greatest discriminatory power (log-rank test, log P = -84.9). Cox-regression analysis showed that the TNM system was the most powerful determinant of cancer-specific survival curves. Proportion of variance explained (PVE) analysis showed that the TNM system had the highest PVE.

CONCLUSION

Of the prognostic classification systems analysed in this study, the TNM system performs best in all the three analyses, and is therefore the most suitable for predicting outcome in DTC-patients.

摘要

目的

识别和比较基于基本肿瘤特征的分化型甲状腺癌(DTC)的预后分类系统,这些系统是为 DTC 开发和/或验证的。

设计

回顾性图表研究。

方法

使用 PubMed 研究文献。确定了 15 种不同的预后分类系统,其中 7 种是针对 DTC 患者开发或验证的,基于基本肿瘤特征。将这些系统应用于 1978 年至 2002 年在我院治疗的 1225 例 DTC 患者。

结果

Kaplan-Meier 癌症特异性生存曲线的对数秩分析显示,TNM 系统的曲线具有最大的判别能力(对数秩检验,log P =-84.9)。Cox 回归分析显示,TNM 系统是癌症特异性生存曲线的最强决定因素。方差解释比例(PVE)分析显示,TNM 系统具有最高的 PVE。

结论

在本研究分析的预后分类系统中,TNM 系统在所有三个分析中表现最佳,因此最适合预测 DTC 患者的预后。

相似文献

1
A comparison of prognostic classification systems for differentiated thyroid carcinoma.分化型甲状腺癌的预后分类系统比较。
Clin Endocrinol (Oxf). 2010 Jun;72(6):830-8. doi: 10.1111/j.1365-2265.2009.03734.x. Epub 2009 Oct 31.
2
Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.采用美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)第六版TNM分期系统对分化型甲状腺癌进行再分期:分期迁移与可预测性。
Ann Surg Oncol. 2007 May;14(5):1551-9. doi: 10.1245/s10434-006-9242-2. Epub 2007 Feb 21.
3
A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.不同分期系统对患者预后预测能力的比较。以甲状腺癌为例。
Cancer. 1997 Jun 15;79(12):2414-23.
4
Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.分化型甲状腺癌的临床显著预后因素:一项基于人群的巢式病例对照研究。
Cancer. 2006 Feb 1;106(3):524-31. doi: 10.1002/cncr.21653.
5
AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.甲状腺乳头状癌中的AMES、MACIS和TNM预后分类。
Anticancer Res. 2003 Sep-Oct;23(5b):4283-8.
6
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.分化型甲状腺癌远处转移患者预后的指标
J Am Coll Surg. 2003 Aug;197(2):191-7. doi: 10.1016/S1072-7515(03)00332-6.
7
Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.分化型甲状腺癌初诊时伴远处转移的临床结局和预后因素。
Ann Surg. 2010 Jan;251(1):114-9. doi: 10.1097/SLA.0b013e3181b7faf6.
8
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
9
Need for a revised staging consensus in medullary thyroid carcinoma.甲状腺髓样癌分期共识修订的必要性。
Arch Surg. 2009 Jul;144(7):663-9. doi: 10.1001/archsurg.2009.122.
10
Simplifying the TNM system for clinical use in differentiated thyroid cancer.简化TNM系统以用于分化型甲状腺癌的临床应用。
J Clin Oncol. 2009 Apr 10;27(11):1872-8. doi: 10.1200/JCO.2008.20.2382. Epub 2009 Mar 9.

引用本文的文献

1
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.结合ATA风险系统的动态风险分层预测甲状腺乳头状癌的长期预后
Cancers (Basel). 2023 Sep 21;15(18):4656. doi: 10.3390/cancers15184656.
2
Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.评估分化型甲状腺癌中风险分层和 TNM 系统的疾病特异性生存预测。
J Clin Endocrinol Metab. 2023 May 17;108(6):e267-e274. doi: 10.1210/clinem/dgac721.
3
The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis.
微小RNA在甲状腺癌中的预后价值——一项系统评价和荟萃分析
Cancers (Basel). 2020 Sep 12;12(9):2608. doi: 10.3390/cancers12092608.
4
Pediatric papillary thyroid cancer: current management challenges.小儿乳头状甲状腺癌:当前的管理挑战
Onco Targets Ther. 2016 Dec 28;10:165-175. doi: 10.2147/OTT.S100512. eCollection 2017.
5
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.小儿分化型甲状腺癌全甲状腺切除及¹³¹I治疗后成功消融和完全缓解的决定因素。
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1390-8. doi: 10.1007/s00259-015-3076-8. Epub 2015 Jun 13.
6
Differentiated thyroid cancer-personalized therapies to prevent overtreatment.分化型甲状腺癌——预防过度治疗的个体化治疗。
Nat Rev Endocrinol. 2014 Sep;10(9):563-74. doi: 10.1038/nrendo.2014.100. Epub 2014 Jul 1.
7
Prognostic biomarkers in thyroid cancer.甲状腺癌的预后生物标志物。
Virchows Arch. 2014 Mar;464(3):333-46. doi: 10.1007/s00428-013-1521-2. Epub 2014 Feb 1.
8
New insights in risk stratification of differentiated thyroid cancer.分化型甲状腺癌风险分层的新见解。
Curr Opin Oncol. 2014 Jan;26(1):1-7. doi: 10.1097/CCO.0000000000000022.
9
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.验证 QTNM 分期系统在分化型甲状腺癌患者中的癌症特异性生存预测价值。
Endocrine. 2014 Jun;46(2):300-8. doi: 10.1007/s12020-013-0078-9. Epub 2013 Oct 31.
10
Thyroid gland: Can a nomogram predict death in patients with thyroid cancer?甲状腺:列线图能否预测甲状腺癌患者的死亡情况?
Nat Rev Endocrinol. 2013 Apr;9(4):192-3. doi: 10.1038/nrendo.2013.45. Epub 2013 Mar 5.